I

InnoCare Pharma
9969

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
HK$33.45B
EV
HK$27.42B
Shares Outstanding
1.76B
Beta
0.94

Wall Street View

Analyst Rating
BUY
Analyst Target Price
HK$14.34
P/E 2025E
-
P/Revenue 2025E
20.32x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About InnoCare Pharma Limited

gainify

I

InnoCare Pharma Limited

9969

InnoCare Pharma Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases. It develops Orelabrutinib, an BTK inhibitor to treat patients with relapsed and/or refractory (r/r)...

Sector

Healthcare

Industry

Biotechnology

CEO

Cui, Jisong

Employees

1,176

IPO Date

2020-03-23

Headquarters

Building 8, No. 8 Life Science Park Road, Zhongguancun Life Science Park, Changping District, Beijing 102206, China

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.